advertisement

Meds and you

28 April 2011

Adcock ordered to withdraw painkillers

Adcock Ingram Holdings has three months to withdraw all medicines containing dextropropoxyphene after the MCC cancelled the South African registration of such medicines.

Adcock Ingram Holdings has three months to withdraw all medicines containing dextropropoxyphene (DPP) after the Medicines Control Council (MCC) cancelled the South African registration of such medicines.

In an investigation the FDA found that DPP’s safety risks outweighed its analgesic benefits. The FDA asked suppliers to voluntarily remove all medicines containing DPP from the American market.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.